(Q53674865)

17 May 2018

title

MicroRNA miR-150 is involved in Vα14 invariant NKT cell development and function. (English)

1 reference

17 May 2018

1 reference

Quanhui Zheng

1

1 reference

17 May 2018

Li Zhou

series ordinal

2

1 reference

17 May 2018

Qing-Sheng Mi

series ordinal

3

1 reference

17 May 2018

language of work or name

English

0 references

publication date

27 January 2012

1 reference

17 May 2018

published in

Journal of Immunology

1 reference

17 May 2018

volume

188

1 reference

17 May 2018

issue

5

1 reference

17 May 2018

page(s)

2118-2126

1 reference

17 May 2018

miR-150, a microRNA expressed in mature B and T cells, blocks early B cell development when expressed prematurely

cites work

1 reference

12 December 2020

Independent regulation of c-myc, B-myb, and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes

1 reference

12 December 2020

Role for IL-15/IL-15 receptor beta-chain in natural killer 1.1+ T cell receptor-alpha beta+ cell development

1 reference

12 December 2020

Granulocyte-Macrophage Colony-Stimulating Factor Regulates Effector Differentiation of Invariant Natural Killer T Cells during Thymic Ontogeny

1 reference

12 December 2020

A key role for Itk in both IFN gamma and IL-4 production by NKT cells.

1 reference

12 December 2020

A thymic precursor to the NK T cell lineage

1 reference

12 December 2020

NK T cell precursors exhibit differential cytokine regulation and require Itk for efficient maturation

1 reference

12 December 2020

The transcription factor c-Myb primes CD4+CD8+ immature thymocytes for selection into the iNKT lineage

1 reference

12 December 2020

Loss of IFN-gamma production by invariant NK T cells in advanced cancer.

1 reference

12 December 2020

Rel/NF-kappaB family member RelA regulates NK1.1- to NK1.1+ transition as well as IL-15-induced expansion of NKT cells

1 reference

12 December 2020

Loss of microRNAs in thymus perturbs invariant NKT cell development and function

1 reference

12 December 2020

A reversible defect in natural killer T cell function characterizes the progression of premalignant to malignant multiple myeloma

1 reference

12 December 2020

The gene encoding early growth response 2, a target of the transcription factor NFAT, is required for the development and maturation of natural killer T cells

1 reference

12 December 2020

An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans.

1 reference

12 December 2020

Many roads to maturity: microRNA biogenesis pathways and their regulation

1 reference

12 December 2020

The unique role of natural killer T cells in the response to microorganisms

1 reference

12 December 2020

NKT cells derive from double-positive thymocytes that are positively selected by CD1d

1 reference

12 December 2020

Dicer-dependent microRNA pathway controls invariant NKT cell development.

1 reference

12 December 2020

Genetic evidence supporting selection of the Valpha14i NKT cell lineage from double-positive thymocyte precursors

1 reference

12 December 2020

Critical functions for c-Myb at three checkpoints during thymocyte development

1 reference

12 December 2020

MiR-150 controls B cell differentiation by targeting the transcription factor c-Myb

1 reference

12 December 2020

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

1 reference

12 December 2020

miR-150 regulates the development of NK and iNKT cells

1 reference

12 December 2020

Regulation of human T-lymphocyte gene expression by interleukin 2: immediate-response genes include the proto-oncogene c-myb

1 reference

12 December 2020

Constitutive Cytokine mRNAs Mark Natural Killer (NK) and NK T Cells Poised for Rapid Effector Function

1 reference

12 December 2020

Tie2cre-induced inactivation of the miRNA-processing enzyme Dicer disrupts invariant NKT cell development

1 reference

12 December 2020

Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation

1 reference

12 December 2020

c-Myb is essential for early T cell development

1 reference

12 December 2020

PLZF induces the spontaneous acquisition of memory/effector functions in T cells independently of NKT cell-related signals

1 reference

12 December 2020

The transcription factor PLZF directs the effector program of the NKT cell lineage

1 reference

12 December 2020

The biology of NKT cells

1 reference

12 December 2020

An IL-2 receptor beta subdomain that controls Bcl-X(L) expression and cell survival

1 reference

12 December 2020

An invariant T cell receptor alpha chain defines a novel TAP-independent major histocompatibility complex class Ib-restricted alpha/beta T cell subpopulation in mammals

1 reference

12 December 2020

SLAM receptors and SAP influence lymphocyte interactions, development and function

1 reference

12 December 2020

c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3.

1 reference

12 December 2020

The adaptor molecule signaling lymphocytic activation molecule-associated protein (SAP) regulates IFN-gamma and IL-4 production in V alpha 14 transgenic NKT cells via effects on GATA-3 and T-bet expression

1 reference

12 December 2020

MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3'-untranslated region of the gene that decrease steady-state levels of the transcript

1 reference

12 December 2020

NIK-dependent RelB activation defines a unique signaling pathway for the development of V alpha 14i NKT cells

1 reference

12 December 2020

The interleukin-4 enhancer CNS-2 is regulated by Notch signals and controls initial expression in NKT cells and memory-type CD4 T cells.

1 reference

12 December 2020

Costimulation of multiple NK cell activation receptors by NKG2D.

1 reference

12 December 2020

Homeostasis of V alpha 14i NKT cells

1 reference

12 December 2020

Immune cell crosstalk in type 1 diabetes

1 reference

12 December 2020

Toward an understanding of NKT cell biology: progress and paradoxes

1 reference

12 December 2020

Reversible defects in natural killer and memory CD8 T cell lineages in interleukin 15-deficient mice

1 reference

12 December 2020

T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells

1 reference

12 December 2020

Slam haplotypes modulate the response to lipopolysaccharide in vivo through control of NKT cell number and function

1 reference

12 December 2020

MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.

1 reference

12 December 2020

Proper levels of c-Myb are discretely defined at distinct steps of hematopoietic cell development

1 reference

12 December 2020

GATA-1 and c-myb crosstalk during red blood cell differentiation through GATA-1 binding sites in the c-myb promoter.

1 reference

12 December 2020

P2X7 receptors regulate NKT cells in autoimmune hepatitis

1 reference

12 December 2020

An invariant V alpha 24-J alpha Q/V beta 11 T cell receptor is expressed in all individuals by clonally expanded CD4-8- T cells

1 reference

12 December 2020

Impaired NK1+ T cell development and early IL-4 production in CD1-deficient mice.

1 reference

12 December 2020

T-bet concomitantly controls migration, survival, and effector functions during the development of Valpha14i NKT cells

1 reference

12 December 2020

A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage

1 reference

12 December 2020

Mouse CD1-specific NK1 T cells: development, specificity, and function

1 reference

12 December 2020

NF-kappa B controls cell fate specification, survival, and molecular differentiation of immunoregulatory natural T lymphocytes.

1 reference

12 December 2020

GATA-3 regulates the development and function of invariant NKT cells

1 reference

12 December 2020

Activation of natural killer T cells by alpha-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes

1 reference

12 December 2020

Identifiers

DOI

10.4049/JIMMUNOL.1103342

1 reference

17 May 2018

release_rmhqyowysvd7rir3qxacgta2y4

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rmhqyowysvd7rir3qxacgta2y4

24 November 2022

mapped directly with Wikidata item

PMC publication ID

7375412

0 references

1 reference

17 May 2018